Heading Toward the Elimination of Hepatitis C Virus
2018
Chronic hepatitis C is often asymptomatic and may progress over the years to cirrhosis and hepatocellular carcinoma. Although the
prevalence and incident cases are decreasing, the peak mortality of hepatitis C virus (HCV)-related complications is ahead of us in most
countries. The economic impact of this burden is enormous. Scaling up the identification of new opportunities to facilitate the road
toward HCV elimination includes increasing screening, awareness, and the number of prescribing physicians. Screening should occur
within the context of linkage-to-care and patient retention across the care continuum. Awareness and access to treatment in different
countries are not systematic as countries have diverse healthcare organizations so that treatment eligibility and availability criteria vary
significantly. The simplicity of oral regimens with direct-acting antiviral drugs that are effective across HCV genotypes expands the
number of physicians who can prescribe them with accessible treatment models. The ultimate aim is the elimination of HCV by 2030.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI